How Will I Treat This Patient? - Case Series

First-Line Therapy for Metastatic Pancreatic Cancer: A Case-Based Review of Current Evidence
First-Line Therapy for Metastatic Pancreatic Cancer: A Case-Based Review of Current Evidence
CME, CPE
Namrata Vijayvergia, MD, and Steven J. Cohen, MD
Release Date: July 15, 2015
Expiration Date: July 15, 2016
This activity will explore the management of a 64-year-old female patient presenting with non-resectable metastatic pancreatic cancer. This case will explore appropriate combination regimens for frontline therapy for good performance status patients with metastatic pancreatic cancer examining new classes of treatments, new formulations of existing drugs, and potential emerging treatment options.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Aduro BioTech.
View Only, CE ExpiredView Only, No Credit
 
Patient with Advanced, Inoperable Pancreatic Cancer
Patient with Advanced, Inoperable Pancreatic Cancer
CME, CPE
Susan J. Littman, MD
Release Date: November 05, 2014
Expiration Date: November 05, 2015
In this case, Dr. Susan Littman reviews clinical treatment challenges associated with pancreatic cancer including how anatomy influences the clinical presentation of pancreatic cancer, the initial diagnostic workup and staging of pancreatic cancer, indications for surgical resection and factors determining resectability, caveats to elevations in Ca19.9, and therapeutic options beyond surgery for metastatic disease.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Aduro BioTech.
View Only, CE ExpiredView Only, No Credit
 

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of PartnersinPancreaticCancer.com.

©2017 MediCom Worldwide, Inc. All rights reserved